Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychiatry (Edgmont). 2005 Dec;2(12):40-3.

Promising pharmacotherapy on the horizon for nicotine dependence.

Author information

1
Dr. Berrettini is the Karl E. Rickels Professor of Psychiatry, Director, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

Abstract

Nicotine dependence pharmacotherapy is important to psychiatrists, as epidemiological studies indicate that a majority of individuals with schizophrenia or affective disorders are daily smokers. The epidemiology of nicotine dependence and the efficacy of nicotine dependence pharmacotherapies are reviewed briefly. Then, novel pharmacotherapies for which FDA approval is expected next year are described.

PMID:
21120114
PMCID:
PMC2994239
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center